General Archive
-
News releases
MRC Technology supports Parkinson’s UK through its research grant terms approval service
Parkinson’s UK is the latest medical research funder to benefit from its recently launched research grant terms approval service. As…
-
News releases
MRC Technology launches small molecule compound library access scheme
Scheme provides access to a representative subset of 9,000 compounds from 150,000 strong small molecule compound library to academic research…
-
News releases
Intellect Neurosciences and MRC Technology announce humanization of next-generation monoclonal antibody to amyloid beta with reduced potential for inflammation in the brain of Alzheimer’s patients
MRC Technology and Intellect Neurosciences have completed humanization of 82E1, a mouse monoclonal antibody to create a high-affinity stabilized IgG4…
-
News releases
New postpartum haemorrhage drug discovery project launched
A collaboration between MRC Technology and Dr Andrew Blanks at the University of Warwick has been launched to develop inhibitors…
-
News releases
GPCR collaboration with Heptares extended
The collaboration covers the structure and active conformations of G-protein coupled receptors (GPCRs), and other transmembrane proteins. Building upon their…
-
News releases
New ACTH-dependent Cushing’s Syndrome drug discovery project launched
Collaboration between MRC Technology and Queen Mary University of London to develop melanocortin receptor type 2 (MC2R) antagonists for the…
-
News releases
New drug discovery collaborations with Queen Mary University of London launched
The first collaboration will develop selective formyl peptide receptor 2 (FPR2) agonists for the treatment of ischaemia reperfusion injury. The…
-
News releases
MRCT announce second drug discovery collaboration with University of Bristol
This project will focus on developing novel modulators of the second galanin receptor subtype (GalR2) for neuropathic pain, a major…
-
News releases
Mount Sinai School of Medicine and MRC Technology to collaborate on monoclonal antibody production and humanization
The collaboration will focus on the development of monoclonal antibodies that can be commercialized as drugs to control infection and…
-
News releases
MRC Technology launches research grant terms approval service
The newly-launched research grant terms approval service, provided the MS Society with the first review. As an expert in commercialising…
-
News releases
Phosphate Therapeutics acquires novel phosphate binder (PT20) from the Medical Research Council and secures development funding from Inventages venture capital for compound’s phase 2 development
Phosphate Therapeutics has acquired the global rights to PT20, a novel Phase 2 ready phosphate binder for the treatment of…
-
News releases
New drug discovery collaboration with University of Bristol launched
Collaboration aims to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.